BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25835739)

  • 1. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice.
    Tolba R; Kraus T; Liedtke C; Schwarz M; Weiskirchen R
    Lab Anim; 2015 Apr; 49(1 Suppl):59-69. PubMed ID: 25835739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse.
    Vesselinovitch SD; Mihailovich N
    Cancer Res; 1983 Sep; 43(9):4253-9. PubMed ID: 6871863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
    BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats.
    Ghosh A; Ghosh D; Sarkar S; Mandal AK; Thakur Choudhury S; Das N
    Eur J Cancer Prev; 2012 Jan; 21(1):32-41. PubMed ID: 21968689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
    Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
    PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rac1 promotes diethylnitrosamine (DEN)-induced formation of liver tumors.
    Bopp A; Wartlick F; Henninger C; Schwarz M; Kaina B; Fritz G
    Carcinogenesis; 2015 Mar; 36(3):378-89. PubMed ID: 25556150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat.
    Michel C; Desdouets C; Slaoui M; Isaacs KR; Roberts RA; Boitier E
    Toxicol Sci; 2007 Sep; 99(1):58-69. PubMed ID: 17602206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous induction of liver cirrhosis and hepatocellular carcinomas in F-344 rats: establishment of a short hepatocarcinogenesis model.
    Zalatnai A; Lapis K
    Exp Toxicol Pathol; 1994 Aug; 46(3):215-22. PubMed ID: 8000242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
    Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
    J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-diethylnitrosamine mouse hepatotoxicity: time-related effects on histology and oxidative stress.
    Paula Santos N; Colaço A; Gil da Costa RM; Manuel Oliveira M; Peixoto F; Alexandra Oliveira P
    Exp Toxicol Pathol; 2014 Dec; 66(9-10):429-36. PubMed ID: 25097018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increase of general toxic effects and decrease of hepatocarcinogenic effects of diethylnitrosamine administered to mice in conjunction with isopropanol].
    Kaledin VI; Baginskaia NV; Vasiunina EA; Il'nitskaia SI; Ovchinnikova LP
    Vopr Onkol; 2012; 58(5):658-62. PubMed ID: 23600284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice.
    Kushida M; Kamendulis LM; Peat TJ; Klaunig JE
    Toxicol Pathol; 2011 Aug; 39(5):776-86. PubMed ID: 21628716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alcohol on diethylnitrosamine-induced hepatic toxicity: Critical role of ROS, lipid accumulation, and mitochondrial dysfunction.
    Sun Q; Long Z; Wu H; Liu Y; Wang L; Zhang X; Wang X; Hai C
    Exp Toxicol Pathol; 2015 Oct; 67(10):491-8. PubMed ID: 26198575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine does no promote esophageal carcinogenesis in rats exposed to diethylnitrosamine.
    Dillenburg CF; Kruel CD; Cerski CT; Edelweiss MI; Silva TL; Schier AS
    Arq Gastroenterol; 2008; 45(1):87-92. PubMed ID: 18425235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histology, bioenergetics and oxidative stress in mouse liver exposed to N-diethylnitrosamine.
    Santos NP; Pereira IC; Pires MJ; Lopes C; Andrade R; Oliveira MM; Colaço A; Peixoto F; Oliveira PA
    In Vivo; 2012; 26(6):921-9. PubMed ID: 23160673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
    Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S
    Cancer Lett; 2007 Feb; 246(1-2):115-21. PubMed ID: 16569478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of hepatic neoplasms in lower vertebrate animals as a tool in cancer research.
    Ishikawa T; Takayama S
    J Toxicol Environ Health; 1979; 5(2-3):537-50. PubMed ID: 469953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-nitrosodiethylamine mouse model: sketching a timeline of evolution of chemically-induced hepatic lesions.
    Da Costa RM; Paula-Santos N; Rocha AF; Colaço A; Lopes C; Oliveira PA
    Anticancer Res; 2014 Dec; 34(12):7029-37. PubMed ID: 25503129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of liver preneoplasia and gallbladder agenesis in turkey fetuses administered diethylnitrosamine.
    Williams GM; Brunnemann KD; Iatropoulos MJ; Smart DJ; Enzmann HG
    Arch Toxicol; 2011 Jun; 85(6):681-7. PubMed ID: 20981410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Solanum trilobatum on the antioxidant status during diethyl nitrosamine induced and phenobarbital promoted hepatocarcinogenesis in rat.
    Shahjahan M; Vani G; Shyamaladevi CS
    Chem Biol Interact; 2005 Oct; 156(2-3):113-23. PubMed ID: 16188247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.